Summary

Global Dry Eye Syndrome Drugs Market 2023-2027
The dry eye syndrome drugs market is forecasted to grow by USD 2,159.21 mn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, growing healthcare expenditure, and changing lifestyles and rising cases of diseases contributing to dry eye syndrome.
Technavio's dry eye syndrome drugs market is segmented as below:
By Distribution Channel
• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
By Product
• OTC drugs
• Prescription drugs
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advancements in drug delivery technologies as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years. Also, advancements in diagnostic techniques for dry eye syndrome and the shift of dry eye syndrome drugs toward personalized medicine will lead to sizable demand in the market.
The report on the dry eye syndrome drugs market covers the following areas:
• Dry eye syndrome drugs market sizing
• Dry eye syndrome drugs market forecast
• Dry eye syndrome drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co. LLC, Bausch Health Co. Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires THEA SAS, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarma. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/dry-eye-syndrome-drugs-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global dry eye syndrome drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 6.4 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 OTC drugs - Market size and forecast 2022-2027
o Exhibit 52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
o 7.4 Prescription drugs - Market size and forecast 2022-2027
o Exhibit 56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Japan - Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories - Overview
o Exhibit 112: Abbott Laboratories - Business segments
o Exhibit 113: Abbott Laboratories - Key news
o Exhibit 114: Abbott Laboratories - Key offerings
o Exhibit 115: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 116: AbbVie Inc. - Overview
o Exhibit 117: AbbVie Inc. - Product / Service
o Exhibit 118: AbbVie Inc. - Key news
o Exhibit 119: AbbVie Inc. - Key offerings
o 12.5 AFT Pharmaceuticals Ltd.
o Exhibit 120: AFT Pharmaceuticals Ltd. - Overview
o Exhibit 121: AFT Pharmaceuticals Ltd. - Business segments
o Exhibit 122: AFT Pharmaceuticals Ltd. - Key offerings
o Exhibit 123: AFT Pharmaceuticals Ltd. - Segment focus
o 12.6 Bausch Health Co. Inc.
o Exhibit 124: Bausch Health Co. Inc. - Overview
o Exhibit 125: Bausch Health Co. Inc. - Business segments
o Exhibit 126: Bausch Health Co. Inc. - Key news
o Exhibit 127: Bausch Health Co. Inc. - Key offerings
o Exhibit 128: Bausch Health Co. Inc. - Segment focus
o 12.7 I MED Pharma Inc.
o Exhibit 129: I MED Pharma Inc. - Overview
o Exhibit 130: I MED Pharma Inc. - Product / Service
o Exhibit 131: I MED Pharma Inc. - Key offerings
o 12.8 Johnson and Johnson Services Inc.
o Exhibit 132: Johnson and Johnson Services Inc. - Overview
o Exhibit 133: Johnson and Johnson Services Inc. - Business segments
o Exhibit 134: Johnson and Johnson Services Inc. - Key news
o Exhibit 135: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 136: Johnson and Johnson Services Inc. - Segment focus
o 12.9 Laboratoires THEA SAS
o Exhibit 137: Laboratoires THEA SAS - Overview
o Exhibit 138: Laboratoires THEA SAS - Product / Service
o Exhibit 139: Laboratoires THEA SAS - Key offerings
o 12.10 Mitotech SA
o Exhibit 140: Mitotech SA - Overview
o Exhibit 141: Mitotech SA - Product / Service
o Exhibit 142: Mitotech SA - Key offerings
o 12.11 Novaliq GmbH
o Exhibit 143: Novaliq GmbH - Overview
o Exhibit 144: Novaliq GmbH - Product / Service
o Exhibit 145: Novaliq GmbH - Key offerings
o 12.12 Novartis AG
o Exhibit 146: Novartis AG - Overview
o Exhibit 147: Novartis AG - Business segments
o Exhibit 148: Novartis AG - Key offerings
o Exhibit 149: Novartis AG - Segment focus
o 12.13 Oasis Medical Inc.
o Exhibit 150: Oasis Medical Inc. - Overview
o Exhibit 151: Oasis Medical Inc. - Product / Service
o Exhibit 152: Oasis Medical Inc. - Key offerings
o 12.14 Otsuka Holdings Co. Ltd.
o Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus
o 12.15 Santen Pharmaceutical Co. Ltd.
o Exhibit 157: Santen Pharmaceutical Co. Ltd. - Overview
o Exhibit 158: Santen Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 159: Santen Pharmaceutical Co. Ltd. - Key offerings
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 160: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 162: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. - Overview
o Exhibit 164: Viatris Inc. - Business segments
o Exhibit 165: Viatris Inc. - Key news
o Exhibit 166: Viatris Inc. - Key offerings
o Exhibit 167: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories - Overview
Exhibits112: Abbott Laboratories - Business segments
Exhibits113: Abbott Laboratories - Key news
Exhibits114: Abbott Laboratories - Key offerings
Exhibits115: Abbott Laboratories - Segment focus
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key news
Exhibits119: AbbVie Inc. - Key offerings
Exhibits120: AFT Pharmaceuticals Ltd. - Overview
Exhibits121: AFT Pharmaceuticals Ltd. - Business segments
Exhibits122: AFT Pharmaceuticals Ltd. - Key offerings
Exhibits123: AFT Pharmaceuticals Ltd. - Segment focus
Exhibits124: Bausch Health Co. Inc. - Overview
Exhibits125: Bausch Health Co. Inc. - Business segments
Exhibits126: Bausch Health Co. Inc. - Key news
Exhibits127: Bausch Health Co. Inc. - Key offerings
Exhibits128: Bausch Health Co. Inc. - Segment focus
Exhibits129: I MED Pharma Inc. - Overview
Exhibits130: I MED Pharma Inc. - Product / Service
Exhibits131: I MED Pharma Inc. - Key offerings
Exhibits132: Johnson and Johnson Services Inc. - Overview
Exhibits133: Johnson and Johnson Services Inc. - Business segments
Exhibits134: Johnson and Johnson Services Inc. - Key news
Exhibits135: Johnson and Johnson Services Inc. - Key offerings
Exhibits136: Johnson and Johnson Services Inc. - Segment focus
Exhibits137: Laboratoires THEA SAS - Overview
Exhibits138: Laboratoires THEA SAS - Product / Service
Exhibits139: Laboratoires THEA SAS - Key offerings
Exhibits140: Mitotech SA - Overview
Exhibits141: Mitotech SA - Product / Service
Exhibits142: Mitotech SA - Key offerings
Exhibits143: Novaliq GmbH - Overview
Exhibits144: Novaliq GmbH - Product / Service
Exhibits145: Novaliq GmbH - Key offerings
Exhibits146: Novartis AG - Overview
Exhibits147: Novartis AG - Business segments
Exhibits148: Novartis AG - Key offerings
Exhibits149: Novartis AG - Segment focus
Exhibits150: Oasis Medical Inc. - Overview
Exhibits151: Oasis Medical Inc. - Product / Service
Exhibits152: Oasis Medical Inc. - Key offerings
Exhibits153: Otsuka Holdings Co. Ltd. - Overview
Exhibits154: Otsuka Holdings Co. Ltd. - Business segments
Exhibits155: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits156: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits157: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits158: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits160: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Viatris Inc. - Overview
Exhibits164: Viatris Inc. - Business segments
Exhibits165: Viatris Inc. - Key news
Exhibits166: Viatris Inc. - Key offerings
Exhibits167: Viatris Inc. - Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations